HOPAmbassadors

Introducing HOPAmbassadors

HOPAmbassadors are champions of HOPA and the hematology/oncology pharmacy profession. This group of enthusiastic HOPA Members will represent our organization and hem/onc pharmacy practice in a variety of settings.

Ambassadors for our Association - and, our Profession

HOPAmbassadors will educate patient advocacy groups about the role of the oncology pharmacist, share the latest hem/onc pharmacy science with other oncology providers, visit schools of pharmacy to spark interest in the specialty, and lobby at Capitol Hill in Washington, D.C.

Past President, HOPAmbassador 2023 Larry W. Buie PharmD, BCOP, FCCP, FASHP

Past President, HOPAmbassador 2023 David DeRemer Pharm.D., BCOP, FCCP, FHOPA

HOPAmbassador 2023 Karen Fancher PharmD, BCOP

HOPAmbassador 2023 Lisa Holle PharmD, BCOP, FHOPA, FISOPP

HOPAmbassador 2023 Amanda Seddon PharmD, BCPS, BCOP

Featured Articles

An image of Acute Myeloid Leukemia cells

HOPA News

Late-Breaking HOPA News: The Evolving Landscape of NPM1-Mutated AML

November 24, 2025

Moh'd Mohanad A. Al-Dabet, PhD, AHI(AMT); Katia Al-Sawalha, BSc; and Olivia White, PharmD, BCOP, review revumenib and ziftomenib for NPM-1m disease and highlight key considerations when implementing these two therapies.

Advocacy

What HOPA Members Should Know About the End of the 2025 U.S. Government Shutdown

November 14, 2025

On Wednesday, November 12, Congress passed a continuing resolution to re-open the government after a record 43-day shutdown. Here's what HOPA members should know about the bill and what's happening next.

Advocacy

HOPA Endorses ISOPP & UICC Statement on Ensuring International Cancer Drug Quality and Equity

November 04, 2025

ISOPP and UICC recently released a statement calling for quality and equity of cancer treatments in sub-Saharan Africa. HOPA has joined with oncology and pharmacy organizations worldwide to endorse their statement.